Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis

Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Circulation (New York, N.Y.) Ročník 143; číslo 24; s. 2370
Hlavní autori:	Segar, Matthew W, Jaeger, Byron C, Patel, Kershaw V, Nambi, Vijay, Ndumele, Chiadi E, Correa, Adolfo, Butler, Javed, Chandra, Alvin, Ayers, Colby, Rao, Shreya, Lewis, Alana A, Raffield, Laura M, Rodriguez, Carlos J, Michos, Erin D, Ballantyne, Christie M, Hall, Michael E, Mentz, Robert J, de Lemos, James A, Pandey, Ambarish
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 15.06.2021
Predmet:	Aged Black People Cohort Studies Electrocardiography Female Heart Failure - diagnosis Heart Failure - epidemiology Heart Failure - ethnology Humans Machine Learning Male Middle Aged Prevalence Race Factors Retrospective Studies Risk Factors Socioeconomic Factors Troponin I - blood White People epidemiology heart failure risk machine learning
ISSN:	1524-4539, 1524-4539
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling techniques to develop race-specific HF risk prediction models and to elucidate important contributors of HF development across races. We performed a retrospective analysis of 4 large, community cohort studies (ARIC [Atherosclerosis Risk in Communities], DHS [Dallas Heart Study], JHS [Jackson Heart Study], and MESA [Multi-Ethnic Study of Atherosclerosis]) with adjudicated HF events. The study included participants who were >40 years of age and free of HF at baseline. Race-specific ML models for HF risk prediction were developed in the JHS cohort (for Black race-specific model) and White adults from ARIC (for White race-specific model). The models included 39 candidate variables across demographic, anthropometric, medical history, laboratory, and electrocardiographic domains. The ML models were externally validated and compared with prior established traditional and non-race-specific ML models in race-specific subgroups of the pooled MESA/DHS cohort and Black participants of ARIC. The Harrell C-index and Greenwood-Nam-D'Agostino χ tests were used to assess discrimination and calibration, respectively. The ML models had excellent discrimination in the derivation cohorts for Black (n=4141 in JHS, C-index=0.88) and White (n=7858 in ARIC, C-index=0.89) participants. In the external validation cohorts, the race-specific ML model demonstrated adequate calibration and superior discrimination (Black individuals, C-index=0.80-0.83; White individuals, C-index=0.82) compared with established HF risk models or with non-race-specific ML models derived with race included as a covariate. Among the risk factors, natriuretic peptide levels were the most important predictor of HF risk across both races, followed by troponin levels in Black and ECG-based Cornell voltage in White individuals. Other key predictors of HF risk among Black individuals were glycemic parameters and socioeconomic factors. In contrast, prevalent cardiovascular disease and traditional cardiovascular risk factors were stronger predictors of HF risk in White adults. Race-specific and ML-based HF risk models that integrate clinical, laboratory, and biomarker data demonstrated superior performance compared with traditional HF risk and non-race-specific ML models. This approach identifies distinct race-specific contributors of HF.
AbstractList	Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling techniques to develop race-specific HF risk prediction models and to elucidate important contributors of HF development across races.BACKGROUNDHeart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling techniques to develop race-specific HF risk prediction models and to elucidate important contributors of HF development across races.We performed a retrospective analysis of 4 large, community cohort studies (ARIC [Atherosclerosis Risk in Communities], DHS [Dallas Heart Study], JHS [Jackson Heart Study], and MESA [Multi-Ethnic Study of Atherosclerosis]) with adjudicated HF events. The study included participants who were >40 years of age and free of HF at baseline. Race-specific ML models for HF risk prediction were developed in the JHS cohort (for Black race-specific model) and White adults from ARIC (for White race-specific model). The models included 39 candidate variables across demographic, anthropometric, medical history, laboratory, and electrocardiographic domains. The ML models were externally validated and compared with prior established traditional and non-race-specific ML models in race-specific subgroups of the pooled MESA/DHS cohort and Black participants of ARIC. The Harrell C-index and Greenwood-Nam-D'Agostino χ2 tests were used to assess discrimination and calibration, respectively.METHODSWe performed a retrospective analysis of 4 large, community cohort studies (ARIC [Atherosclerosis Risk in Communities], DHS [Dallas Heart Study], JHS [Jackson Heart Study], and MESA [Multi-Ethnic Study of Atherosclerosis]) with adjudicated HF events. The study included participants who were >40 years of age and free of HF at baseline. Race-specific ML models for HF risk prediction were developed in the JHS cohort (for Black race-specific model) and White adults from ARIC (for White race-specific model). The models included 39 candidate variables across demographic, anthropometric, medical history, laboratory, and electrocardiographic domains. The ML models were externally validated and compared with prior established traditional and non-race-specific ML models in race-specific subgroups of the pooled MESA/DHS cohort and Black participants of ARIC. The Harrell C-index and Greenwood-Nam-D'Agostino χ2 tests were used to assess discrimination and calibration, respectively.The ML models had excellent discrimination in the derivation cohorts for Black (n=4141 in JHS, C-index=0.88) and White (n=7858 in ARIC, C-index=0.89) participants. In the external validation cohorts, the race-specific ML model demonstrated adequate calibration and superior discrimination (Black individuals, C-index=0.80-0.83; White individuals, C-index=0.82) compared with established HF risk models or with non-race-specific ML models derived with race included as a covariate. Among the risk factors, natriuretic peptide levels were the most important predictor of HF risk across both races, followed by troponin levels in Black and ECG-based Cornell voltage in White individuals. Other key predictors of HF risk among Black individuals were glycemic parameters and socioeconomic factors. In contrast, prevalent cardiovascular disease and traditional cardiovascular risk factors were stronger predictors of HF risk in White adults.RESULTSThe ML models had excellent discrimination in the derivation cohorts for Black (n=4141 in JHS, C-index=0.88) and White (n=7858 in ARIC, C-index=0.89) participants. In the external validation cohorts, the race-specific ML model demonstrated adequate calibration and superior discrimination (Black individuals, C-index=0.80-0.83; White individuals, C-index=0.82) compared with established HF risk models or with non-race-specific ML models derived with race included as a covariate. Among the risk factors, natriuretic peptide levels were the most important predictor of HF risk across both races, followed by troponin levels in Black and ECG-based Cornell voltage in White individuals. Other key predictors of HF risk among Black individuals were glycemic parameters and socioeconomic factors. In contrast, prevalent cardiovascular disease and traditional cardiovascular risk factors were stronger predictors of HF risk in White adults.Race-specific and ML-based HF risk models that integrate clinical, laboratory, and biomarker data demonstrated superior performance compared with traditional HF risk and non-race-specific ML models. This approach identifies distinct race-specific contributors of HF.CONCLUSIONSRace-specific and ML-based HF risk models that integrate clinical, laboratory, and biomarker data demonstrated superior performance compared with traditional HF risk and non-race-specific ML models. This approach identifies distinct race-specific contributors of HF. Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction and do not account for significant parameters such as cardiac biomarkers. Machine learning (ML) may offer advantages over traditional modeling techniques to develop race-specific HF risk prediction models and to elucidate important contributors of HF development across races. We performed a retrospective analysis of 4 large, community cohort studies (ARIC [Atherosclerosis Risk in Communities], DHS [Dallas Heart Study], JHS [Jackson Heart Study], and MESA [Multi-Ethnic Study of Atherosclerosis]) with adjudicated HF events. The study included participants who were >40 years of age and free of HF at baseline. Race-specific ML models for HF risk prediction were developed in the JHS cohort (for Black race-specific model) and White adults from ARIC (for White race-specific model). The models included 39 candidate variables across demographic, anthropometric, medical history, laboratory, and electrocardiographic domains. The ML models were externally validated and compared with prior established traditional and non-race-specific ML models in race-specific subgroups of the pooled MESA/DHS cohort and Black participants of ARIC. The Harrell C-index and Greenwood-Nam-D'Agostino χ tests were used to assess discrimination and calibration, respectively. The ML models had excellent discrimination in the derivation cohorts for Black (n=4141 in JHS, C-index=0.88) and White (n=7858 in ARIC, C-index=0.89) participants. In the external validation cohorts, the race-specific ML model demonstrated adequate calibration and superior discrimination (Black individuals, C-index=0.80-0.83; White individuals, C-index=0.82) compared with established HF risk models or with non-race-specific ML models derived with race included as a covariate. Among the risk factors, natriuretic peptide levels were the most important predictor of HF risk across both races, followed by troponin levels in Black and ECG-based Cornell voltage in White individuals. Other key predictors of HF risk among Black individuals were glycemic parameters and socioeconomic factors. In contrast, prevalent cardiovascular disease and traditional cardiovascular risk factors were stronger predictors of HF risk in White adults. Race-specific and ML-based HF risk models that integrate clinical, laboratory, and biomarker data demonstrated superior performance compared with traditional HF risk and non-race-specific ML models. This approach identifies distinct race-specific contributors of HF.
Author	Rodriguez, Carlos J Raffield, Laura M Segar, Matthew W Rao, Shreya Jaeger, Byron C Ayers, Colby Ndumele, Chiadi E de Lemos, James A Pandey, Ambarish Nambi, Vijay Chandra, Alvin Ballantyne, Christie M Hall, Michael E Correa, Adolfo Lewis, Alana A Mentz, Robert J Michos, Erin D Butler, Javed Patel, Kershaw V
Author_xml	– sequence: 1 givenname: Matthew W surname: Segar fullname: Segar, Matthew W organization: Parkland Health and Hospital System, Dallas, TX (M.W.S., S.R.) – sequence: 2 givenname: Byron C surname: Jaeger fullname: Jaeger, Byron C organization: Department of Biostatistics, University of Alabama at Birmingham (B.C.J.) – sequence: 3 givenname: Kershaw V surname: Patel fullname: Patel, Kershaw V organization: Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, TX (K.V.P.) – sequence: 4 givenname: Vijay surname: Nambi fullname: Nambi, Vijay organization: Section of Cardiology and Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX (V.N.) – sequence: 5 givenname: Chiadi E surname: Ndumele fullname: Ndumele, Chiadi E organization: Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (C.E.N., E.D.M.) – sequence: 6 givenname: Adolfo surname: Correa fullname: Correa, Adolfo organization: Department of Medicine, University of Mississippi Medical Center, Jackson (A.C., J.B., M.E.H.) – sequence: 7 givenname: Javed surname: Butler fullname: Butler, Javed organization: Department of Medicine, University of Mississippi Medical Center, Jackson (A.C., J.B., M.E.H.) – sequence: 8 givenname: Alvin surname: Chandra fullname: Chandra, Alvin organization: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (M.W.S., K.V.P., A.C., C.A., S.R., J.A.d.L., A.P.) – sequence: 9 givenname: Colby surname: Ayers fullname: Ayers, Colby organization: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (M.W.S., K.V.P., A.C., C.A., S.R., J.A.d.L., A.P.) – sequence: 10 givenname: Shreya surname: Rao fullname: Rao, Shreya organization: Parkland Health and Hospital System, Dallas, TX (M.W.S., S.R.) – sequence: 11 givenname: Alana A surname: Lewis fullname: Lewis, Alana A organization: Division of Cardiology, Northwestern University, Chicago, IL (A.A.L.) – sequence: 12 givenname: Laura M surname: Raffield fullname: Raffield, Laura M organization: Department of Genetics, University of North Carolina, Chapel Hill (L.M.R.) – sequence: 13 givenname: Carlos J surname: Rodriguez fullname: Rodriguez, Carlos J organization: Departments of Medicine, Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.J.R.) – sequence: 14 givenname: Erin D surname: Michos fullname: Michos, Erin D organization: Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (C.E.N., E.D.M.) – sequence: 15 givenname: Christie M surname: Ballantyne fullname: Ballantyne, Christie M organization: Michael E. DeBakey Veterans Affairs Hospital and Baylor College of Medicine, Houston, TX (V.N., C.M.B.) – sequence: 16 givenname: Michael E surname: Hall fullname: Hall, Michael E organization: Department of Medicine, University of Mississippi Medical Center, Jackson (A.C., J.B., M.E.H.) – sequence: 17 givenname: Robert J surname: Mentz fullname: Mentz, Robert J organization: Division of Cardiology, Duke Clinical Research Institute, Durham, NC (R.J.M.) – sequence: 18 givenname: James A surname: de Lemos fullname: de Lemos, James A organization: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (M.W.S., K.V.P., A.C., C.A., S.R., J.A.d.L., A.P.) – sequence: 19 givenname: Ambarish surname: Pandey fullname: Pandey, Ambarish organization: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (M.W.S., K.V.P., A.C., C.A., S.R., J.A.d.L., A.P.)
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33845593$$D View this record in MEDLINE/PubMed
BookMark	eNpNUEtPwkAY3BiMPPQvmPXmpbiPFqi3WkVIihgEE0_NdverrC672G1N-Av-ajFi4mkemZnDdFHLOgsIXVDSp3RAr9LpIl1lyXI6f0gmSZ8y0icRpzw8Qh0asTAIIx63_vE26nr_RggZ8GF0gtqcj8IoinkHfd3CJxi33YCtsbAKPwujlai1s9iVeCbkWlvAGYjKavsa3AgPCi-EhOBpC1KXWuKZU2A8rh1-rEBpWWNKgpd9Ay-0f_-ZmexFjcdCm6aCa5zgWWNqLd3a7e3ECrPz2p-i41IYD2cH7KHV-G6ZToJsfj9NkyyQ4TAmAQPGJTBalKGSshwVFMqCA1PACciYFSIeKFHSAoYFxIWKBSOlBDqSEoYxo6yHLn93t5X7aMDX-UZ7CcYIC67xOYso4yGNeLiPnh-iTbEBlW8rvRHVLv_7j30DgrZ4qA
CitedBy_id	crossref_primary_10_1002_clc_23839 crossref_primary_10_3389_fcvm_2022_1011071 crossref_primary_10_1016_j_ijcard_2024_132315 crossref_primary_10_1161_CIRCHEARTFAILURE_123_010879 crossref_primary_10_1093_eurjpc_zwaf334 crossref_primary_10_3389_fcvm_2023_1237258 crossref_primary_10_1371_journal_pone_0288819 crossref_primary_10_1016_j_jchf_2023_06_014 crossref_primary_10_1016_j_jacc_2021_08_020 crossref_primary_10_1186_s12916_024_03273_7 crossref_primary_10_1038_s41598_025_92089_3 crossref_primary_10_1161_JAHA_121_024833 crossref_primary_10_3389_fcvm_2022_848789 crossref_primary_10_1002_ehf2_15066 crossref_primary_10_1161_JAHA_122_029124 crossref_primary_10_3389_fpubh_2023_1033070 crossref_primary_10_3390_bioengineering12050511 crossref_primary_10_1016_j_jacc_2024_09_006 crossref_primary_10_1093_eurheartj_ehab887 crossref_primary_10_3390_jcdd10120488 crossref_primary_10_3389_fsurg_2023_1095505 crossref_primary_10_1016_j_jchf_2023_11_011 crossref_primary_10_1161_CIRCULATIONAHA_121_055565 crossref_primary_10_1016_j_pcad_2024_01_001 crossref_primary_10_3390_app13031509 crossref_primary_10_1016_j_ajpc_2021_100250 crossref_primary_10_1038_s41440_023_01469_7 crossref_primary_10_1016_j_jchf_2022_04_012 crossref_primary_10_1016_j_ejrad_2024_111867 crossref_primary_10_1002_ejhf_3443 crossref_primary_10_1002_ehf2_14665 crossref_primary_10_1016_j_clinbiochem_2022_06_007 crossref_primary_10_1016_j_eswa_2023_119648 crossref_primary_10_1111_ocr_12721 crossref_primary_10_1007_s10916_024_02087_7 crossref_primary_10_3389_fcvm_2023_1119699 crossref_primary_10_1093_ehjdh_ztaf023 crossref_primary_10_1016_j_athoracsur_2021_11_067 crossref_primary_10_1007_s00330_023_09785_9 crossref_primary_10_1016_j_jcct_2025_03_013 crossref_primary_10_3390_jcdd8090106 crossref_primary_10_3389_fcvm_2023_1211600 crossref_primary_10_1093_eurheartj_ehaf517 crossref_primary_10_1016_j_jaccao_2024_04_010 crossref_primary_10_1016_j_hfc_2021_11_001 crossref_primary_10_1002_ejhf_3034 crossref_primary_10_1016_j_heliyon_2024_e29985 crossref_primary_10_14797_mdcvj_1392 crossref_primary_10_1016_j_cjca_2021_08_006 crossref_primary_10_1007_s11042_024_18953_y crossref_primary_10_1038_s44325_024_00031_9 crossref_primary_10_1016_j_cardfail_2021_10_007 crossref_primary_10_1080_23311916_2024_2325635 crossref_primary_10_1093_clinchem_hvab144 crossref_primary_10_1097_CRD_0000000000000851 crossref_primary_10_1161_CIRCHEARTFAILURE_122_009473 crossref_primary_10_3389_fcvm_2022_1022658 crossref_primary_10_1016_j_cmpb_2023_107698 crossref_primary_10_1177_26324636241258265 crossref_primary_10_1111_acer_14802 crossref_primary_10_1097_HCO_0000000000000959 crossref_primary_10_1002_ejhf_2375 crossref_primary_10_1371_journal_pone_0313625 crossref_primary_10_1016_j_inffus_2024_102337 crossref_primary_10_1161_CIRCHEARTFAILURE_121_009401 crossref_primary_10_1016_j_mayocp_2025_01_025 crossref_primary_10_2196_47645 crossref_primary_10_1136_bmjopen_2024_091793
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1161/CIRCULATIONAHA.120.053134
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1524-4539
ExternalDocumentID	33845593
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NHLBI NIH HHS grantid: N01 HC095160 – fundername: NHLBI NIH HHS grantid: HHSN268201100007C – fundername: NHLBI NIH HHS grantid: HHSN268201100012C – fundername: NHLBI NIH HHS grantid: HHSN268201800012I – fundername: NHLBI NIH HHS grantid: N01 HC095165 – fundername: NHLBI NIH HHS grantid: N01 HC095162 – fundername: NHLBI NIH HHS grantid: HHSN268201100008I – fundername: NHLBI NIH HHS grantid: HHSN268201100005G – fundername: NHLBI NIH HHS grantid: HHSN268201800014C – fundername: NCI NIH HHS grantid: HHSN261201800014I
GroupedDBID	--- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 ADKSD ADSXY
ID	FETCH-LOGICAL-c4790-2e23ce21bf4dccf8b1efb3e2de30ec92ba96daf1be7be9bd9a20fce18cce79212
IEDL.DBID	7X8
ISICitedReferencesCount	77
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003017-202106150-00010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1524-4539
IngestDate	Tue Sep 30 22:06:20 EDT 2025 Mon Jul 21 06:00:06 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	24
Keywords	epidemiology heart failure risk machine learning
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4790-2e23ce21bf4dccf8b1efb3e2de30ec92ba96daf1be7be9bd9a20fce18cce79212
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/9976274
PMID	33845593
PQID	2512341534
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2512341534 pubmed_primary_33845593
PublicationCentury	2000
PublicationDate	2021-06-15 20210615
PublicationDateYYYYMMDD	2021-06-15
PublicationDate_xml	– month: 06 year: 2021 text: 2021-06-15 day: 15
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Circulation (New York, N.Y.)
PublicationTitleAlternate	Circulation
PublicationYear	2021
SSID	ssj0006375
Score	2.608414
Snippet	Heart failure (HF) risk and the underlying risk factors vary by race. Traditional models for HF risk prediction treat race as a covariate in risk prediction...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	2370
SubjectTerms	Aged Black People Cohort Studies Electrocardiography Female Heart Failure - diagnosis Heart Failure - epidemiology Heart Failure - ethnology Humans Machine Learning Male Middle Aged Prevalence Race Factors Retrospective Studies Risk Factors Socioeconomic Factors Troponin I - blood White People
Title	Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
URI	https://www.ncbi.nlm.nih.gov/pubmed/33845593 https://www.proquest.com/docview/2512341534
Volume	143
WOSCitedRecordID	wos00003017-202106150-00010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Li9RAEG7UlWUvPnZ1XV_UgnhrN-l00mkvMg4OIzjDMLgynoZ-yqAm62YU_Av-aqs6GdaLIHgJJNBN6K5UVVd9-T7GnpVREW-W5coYwaUwjptMGl7V0ofaOhUGsQk1n9erlV4MBbdugFXufGJy1L51VCM_oziMHrcs5KuLb5xUo6i7OkhoXGd7BaYyZNVqdcUWXhWJaBdDlOSyLPQ-O01OosrPxm-X4_N3PeHslCqC2QsyR9JP_lummSLO5Pb_vusddmvINWHUG8dddi00h-xo1OA5--tPeA4J_ZnK6odsfzY02Y_Yrz-ARGAaDx8wV--ll6CNMEvwywADM-sn_hoDoYelcYEnNfu4cUASa1862LawuKSJt4CO-COOgOWm-0zTTPFmCxOzIVz8SxhB-hWY9Hrx8Y4q5R47n7x5P57yQbKBO6l0xkUQhQsiJ_ifc7G2eYi2CMKHIgtOC2t05U3MbVA2aOu1EVl0Ia-dC0pjGL3PbjRtEx4wqL3XufRaOGMwZ5PaqMqqMubaSkzzshN2ulv8NX4S1OcwTWi_d-ur5T9hx_0Ori967o41nshxtC4e_sPoR-xAEIKFlIrKx2wvokMIT9hN92O76S6fJlvD63wx-w0pGd7_
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+Validation+of+Machine+Learning-Based+Race-Specific+Models+to+Predict+10-Year+Risk+of+Heart+Failure%3A+A+Multicohort+Analysis&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Segar%2C+Matthew+W&rft.au=Jaeger%2C+Byron+C&rft.au=Patel%2C+Kershaw+V&rft.au=Nambi%2C+Vijay&rft.date=2021-06-15&rft.eissn=1524-4539&rft.volume=143&rft.issue=24&rft.spage=2370&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.120.053134&rft_id=info%3Apmid%2F33845593&rft_id=info%3Apmid%2F33845593&rft.externalDocID=33845593
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon